关于在肝硬化中使用专蛋白治疗的争议
Jonel Trebicka1,2,3, Guadalupe Garcia-Tsao4,5
1Department of Internal Medicine B, University of Münster, Münster, Germany.
Hepatology (Baltimore, Md.)
|August 4, 2023
概括
血清白蛋白水平在肝病中降低,影响患者的治疗结果. 虽然静脉注射白蛋白对SBP和AKI等特定疾病有益,但在其他情况下的最佳使用需要进一步研究.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
背景情况:
- 由肝脏合成的白蛋白对于维持性压力和运输物质至关重要.
- 血清白蛋白水平降低是急性和慢性肝病的标志,特别是肝硬化,并预测患者的预后.
- 在晚期肝硬化中,由于氧化应激和炎症,白蛋白质量可能会受到损害.
研究的目的:
- 在与肝脏疾病相关的各种临床环境中批判性地审查静脉注射白素的证据.
- 划分已确定的阿尔伯明治疗的指示与需要进一步研究的领域.
- 为了解决关于最佳剂量,时间和患者选择用于白素输注的不确定性.
主要方法:
- 对现有文献和临床试验数据进行系统审查.
- 批判性评估用于已确立和争论的指示中的白蛋白使用的证据.
- 对影响白素治疗疗效和并发症的因素的分析.
主要成果:
- 建议在特定条件下进行白蛋白输液:大体积,自发细菌性腹膜炎,急性损伤和肝综合征.
- 在其他疾病 (例如感染,低血症,肝脏脑病,一般住院) 中使用专蛋白的证据是有争议的或不确定的.
- 并发症,特别是体积过载,强调了需要精细的方案和仔细的患者选择.
结论:
- 在肝病管理中,在精选的,明确的场景中,使用白蛋白是有益的.
- 对于阿尔伯治疗来说,一种"适合所有人"的方法是不合适的;精确的指示,患者选择和剂量是至关重要的.
- 需要进行更多的随机对照试验,以澄清白蛋白在有争议的临床情况中的作用.
相关概念视频
Drug Distribution: Plasma Protein Binding
5.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.7K
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Factors Affecting Protein-Drug Binding: Patient-Related Factors
82
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
82
Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Hemodialysis II: Procedure and Complications
42
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
42


